Navigation Links
Gene defect linked to dilated cardiomyopathy(DCM)

DCM is a condition which occurs when the heart becomes so enlarged that it is no longer able to pump blood efficiently. The condition affects 35 in every 100,000 people. Researchers in the United States have suggested in a recent study published in the journal Science that a defect in the gene phospholamban may trigger DCM. This gene plays a key role in regulating the flow of calcium through the heart, enabling it to beat effectively. The heart muscle// contracts and relaxes when calcium is released from a reservoir inside into the muscle cell and then pumped back quickly. Scientists have discovered that some people with inherited DCM show a subtle mutation in their phospholamban gene. Patients with DCM may suffer with tiredness, and shortness of breath whilst exercising or even whilst resting. They may have heart palpitations and notice their ankles becoming swollen.

Scientists used tests on mice to determine if a defect in this gene is enough to trigger DCM. They found that a mouse with a defect on the phospholamban gene also suffered severe damage to its heart. Further laboratory tests also showed that this defect disrupts the calcium pump in heart muscle cells. Scientists also found that people with this defect would suffer a chronic malfunction of calcium regulation in their heart muscle. Over time this would lead to heart failure.

Christine Seidman, who led the study, said that the discovery has led to the question of whether heart failure can be prevented if calcium cycle can be restored in this type of defect. The scientists involved in the study believe that this study may help them understand more about heart failure and also in the development of new drugs to treat the condition.


'"/>




Page: 1

Related medicine news :

1. CDC reveals relationship between prepregnant weight and heart defects in infants
2. Sex timing has no impact on risk of Birth defects
3. Infection in pregnancy can lead to congenital eye defects
4. Mutations in NOTCH1 cause an early developmental defect in the aortic valve
5. MicroRNA provides new insight into birth defects
6. Brain defect may play role in stammering
7. Folic acid enriched grain reduces birth defects
8. A call to epileptic mothers to help reduce birth defects
9. Guidant sold defective defibrillators with full knowledge
10. Fungal toxins infected corn the reason for congenital defects
11. Include folic acid in bread to reduce neural tube defects in new borns
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/2/2016)... ... May 02, 2016 , ... ... announced a new Specialty Pharmacy Patient Satisfaction Award that will recognize specialty pharmacies ... quarterly results from Zitter Health Insights’ Specialty Pharmacy Patient Satisfaction Survey compiled throughout ...
(Date:5/2/2016)... ... May 02, 2016 , ... Visceral fat, also known as ... kidneys, liver and pancreas. If not properly addressed, visceral fat can lead to ... Medicine, Medical Oncology and Palliative Care, warns against the dangers of visceral fat. ...
(Date:5/2/2016)... (PRWEB) , ... May 02, ... ... researchers report that many commonly used prescription medications, including anxiolytics, painkillers, antidepressants ... mitigate these risks, Novus Medical Detox Center —a leading Florida-based drug ...
(Date:5/2/2016)... , ... May 02, 2016 , ... Pregnancy Awareness Month ... trying to conceive. , “If you are ready to have a baby, ... “My book, HealthChequesTM: Journal Babies is your Personal Conception & Pregnancy Organizer, written ...
(Date:5/2/2016)... , ... May 02, 2016 , ... ... and urgent care facilities designed to automate and improve the rapid diagnosis, triage ... it is demonstrating their platform, application, and mobile experience for the first time ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)...   Acsis , a leading provider of supply ... research and advisory firm IDC has named it a ... Pharmaceutical Track and Trace Software 2016 Vendor Assessment (doc ... of the capabilities and business strategies of 10 vendors ... Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/28/2016)... 2016 New market research ... a report that provides an overview of the ... by identifying new targets and MOAs to produce ... discussed in this H1 2016 Osteoarthritis Pipeline report ... Inc., Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, ...
(Date:4/27/2016)... 2016   ... sur le trimestre, soutenu par une croissance de ... Croissance de +16% des ventes aux hôpitaux et ... Technologies (Euronext : MKEA, FR0010609263 ; OTCQX : MKEAY), inventeur de ... son chiffre d,affaires pour le premier trimestre clos ...
Breaking Medicine Technology: